<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND AND PURPOSE: We have previously shown that <z:chebi fb="0" ids="16469">17beta-estradiol</z:chebi> reduces infarction volume in female rats </plain></SENT>
<SENT sid="1" pm="."><plain>The present study determined whether single injection or <z:hpo ids='HP_0011010'>chronic</z:hpo> implantation of <z:chebi fb="0" ids="50114">estrogen</z:chebi> confers neuroprotection in male animals with middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (MCAO) and whether there is an interaction with endogenous <z:chebi fb="51" ids="17347">testosterone</z:chebi> </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: Male Wistar rats were treated with 2 hours of reversible MCAO </plain></SENT>
<SENT sid="3" pm="."><plain>In protocol 1, <z:hpo ids='HP_0011009'>acute</z:hpo> versus <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:chebi fb="0" ids="50114">estrogen</z:chebi> administration was examined in groups receiving the following: <z:chebi fb="0" ids="8389">Premarin</z:chebi> (USP) 1 mg/kg IV, immediately before MCAO (<z:hpo ids='HP_0011009'>Acute</z:hpo>, n=13, plasma <z:chebi fb="1" ids="23965">estradiol</z:chebi>=171+/-51 pg/mL); 7 days of 25 microg (E25, n=10, 10+/-3 pg/mL) or 100 microg <z:chebi fb="0" ids="16469">17beta-estradiol</z:chebi> (E100, n=12, 69+/-20 pg/mL) by subcutaneous implant; or saline (SAL, n=21, 3+/-1 pg/mL) </plain></SENT>
<SENT sid="4" pm="."><plain>Laser-Doppler flowmetry was used to monitor the ipsilateral parietal cortex throughout the ischemic period and early reperfusion </plain></SENT>
<SENT sid="5" pm="."><plain>At 22 hours of reperfusion, infarction volume was determined by 0 2,3,5-triphenyltetrazolium <z:chebi fb="76" ids="17996">chloride</z:chebi> staining and image analysis </plain></SENT>
<SENT sid="6" pm="."><plain>In protocol 2, rats were castrated to deplete endogenous <z:chebi fb="51" ids="17347">testosterone</z:chebi> and then treated with <z:chebi fb="1" ids="23965">estradiol</z:chebi> implants: castration only (CAST, n= 13, <z:chebi fb="1" ids="23965">estradiol</z:chebi>=5+/-2 pg/mL), sham-operated (SHAM, n= 10, 4+/-2 pg/mL), <z:chebi fb="1" ids="23965">estradiol</z:chebi> implant 25 microg (CAST+E25, n=16, 7+/-2 pg/mL) or 100 microg (CAST+E100, n=14, 77+/-14 pg/mL) </plain></SENT>
<SENT sid="7" pm="."><plain>RESULTS: Cortical <z:mpath ids='MPATH_124'>infarct</z:mpath> volumes were reduced in <z:hpo ids='HP_0000001'>all</z:hpo> <z:chebi fb="0" ids="50114">estrogen</z:chebi>-treated groups: <z:hpo ids='HP_0011009'>Acute</z:hpo> (21+/-4% of ipsilateral cortex), E25 (12+/-5%), and E100 (12+/-3%) relative to SAL (38+/-5%) </plain></SENT>
<SENT sid="8" pm="."><plain>Caudate infarction was similarly decreased: <z:hpo ids='HP_0011009'>Acute</z:hpo> (39+/-7% of ipsilateral striatum), E25 (25+/-7%), and E100 (34+/-6%) relative to SAL (63+/-4%) </plain></SENT>
<SENT sid="9" pm="."><plain>Castration did not alter ischemic outcome; cortical and caudate infarction (percentage of respective ipsilateral regions) were 37+/-5% and 59+/-5% in CAST and 39+/-7% and 57+/-5% in SHAM, respectively </plain></SENT>
<SENT sid="10" pm="."><plain><z:chebi fb="0" ids="50114">Estrogen</z:chebi> replacement reduced infarction volume in castrated animals in cortex (19+/-4% in CAST+E25 and 12+/-4% in CAST+E100) and in caudate (42+/-6% in CAST+25 and 20+/-7% in CAST + 100) </plain></SENT>
<SENT sid="11" pm="."><plain>Laser-Doppler flowmetry results during <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> and reperfusion was not different among groups </plain></SENT>
<SENT sid="12" pm="."><plain>CONCLUSIONS: Both <z:hpo ids='HP_0011009'>acute</z:hpo> and <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:chebi fb="0" ids="16469">17beta-estradiol</z:chebi> treatments protect male brain in experimental <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
<SENT sid="13" pm="."><plain><z:chebi fb="51" ids="17347">Testosterone</z:chebi> availability does not alter <z:chebi fb="1" ids="23965">estradiol</z:chebi>-mediated tissue salvage after MCAO </plain></SENT>
</text></document>